Dr. Van Morris, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,936 | 8 | 69.2% |
| Unspecified | $8,201 | 5 | 21.1% |
| Food and Beverage | $2,034 | 25 | 5.2% |
| Travel and Lodging | $1,734 | 8 | 4.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $9,895 | 6 | $0 (2024) |
| Incyte Corporation | $6,658 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $6,486 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $5,884 | 6 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $5,551 | 7 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $2,384 | 6 | $0 (2022) |
| Boehringer Ingelheim International GmbH | $1,200 | 1 | $0 (2020) |
| Genentech USA, Inc. | $401.82 | 4 | $0 (2024) |
| Amgen Inc. | $240.90 | 1 | $0 (2021) |
| BioNTech SE | $166.16 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,265 | 16 | Incyte Corporation ($6,658) |
| 2023 | $12,486 | 14 | Novartis Pharmaceuticals Corporation ($6,486) |
| 2022 | $10,357 | 11 | PFIZER INC. ($7,960) |
| 2021 | $240.90 | 1 | Amgen Inc. ($240.90) |
| 2020 | $1,200 | 1 | Boehringer Ingelheim International GmbH ($1,200) |
| 2019 | $233.50 | 2 | Genentech USA, Inc. ($233.50) |
| 2018 | $121.83 | 1 | Genentech USA, Inc. ($121.83) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $5,480.00 | General |
| 11/22/2024 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $466.96 | General |
| 11/22/2024 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $65.55 | General |
| 11/22/2024 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| 11/22/2024 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $26.99 | General |
| 11/21/2024 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $291.96 | General |
| 11/21/2024 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $137.17 | General |
| 11/21/2024 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $82.59 | General |
| 11/21/2024 | Incyte Corporation | — | Travel and Lodging | Cash or cash equivalent | $46.48 | General |
| 10/31/2024 | PFIZER INC. | BRAFTOVI (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $46.49 | General |
| 05/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $135.36 | General |
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $4,900.00 | General |
| 04/02/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $376.12 | General |
| 04/02/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $268.68 | General |
| 04/01/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $81.07 | General |
| Category: Oncology | ||||||
| 09/22/2023 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $6,243.75 | General |
| 07/31/2023 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $100.22 | General |
| 07/31/2023 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $89.57 | General |
| 07/31/2023 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $65.77 | General |
| 07/31/2023 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $40.09 | General |
| 07/31/2023 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $39.96 | General |
| 07/07/2023 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,470.00 | General |
| 07/07/2023 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $745.00 | General |
| 06/02/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $161.45 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ENCORAFENIB AND BINIMETINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $7,960 | 4 |
| 1st Line CRC | Amgen Inc. | $240.90 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 168 | 268 | $103,750 | $23,394 |
| 2022 | 4 | 152 | 268 | $99,279 | $24,785 |
| 2021 | 4 | 153 | 284 | $122,552 | $30,906 |
| 2020 | 4 | 117 | 190 | $64,201 | $13,572 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 54 | 105 | $55,991 | $11,071 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 40 | 80 | $21,120 | $5,809 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 30 | 30 | $18,328 | $4,152 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 38 | $6,476 | $1,931 | 29.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 14 | 15 | $1,835 | $430.65 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 53 | 107 | $54,900 | $12,116 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 52 | 109 | $27,821 | $8,194 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 21 | 21 | $11,480 | $2,919 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 31 | $5,078 | $1,556 | 30.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 71 | 189 | $93,771 | $22,338 | 23.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 41 | 53 | $13,051 | $3,966 | 30.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 25 | 25 | $13,048 | $3,821 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 17 | $2,682 | $780.64 | 29.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 45 | 73 | $34,898 | $5,998 | 17.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 49 | 88 | $20,693 | $5,356 | 25.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 11 | 11 | $5,874 | $1,536 | 26.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 12 | 18 | $2,736 | $681.58 | 24.9% |
About Dr. Van Morris, MD
Dr. Van Morris, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1134396534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Van Morris, MD has received a total of $38,904 in payments from pharmaceutical and medical device companies, with $14,265 received in 2024. These payments were reported across 46 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($26,936).
As a Medicare-enrolled provider, Morris has provided services to 590 Medicare beneficiaries, totaling 1,010 services with total Medicare billing of $92,657. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Durham, NC
- Active Since 05/14/2008
- Last Updated 05/14/2008
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134396534
Products in Payments
- BRAFTOVI (Drug) $5,805
- MEKTOVI (Drug) $3,980
- Nexavar (Drug) $2,384
- Avastin (Biological) $355.33
- Vectibix (Biological) $240.90
- OPDIVO (Biological) $204.22
- TECENTRIQ (Biological) $12.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Durham
Mr. Marat Fudim, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $580,115
Dr. Joseph Mammarappallil, Phd, Md, PHD, MD
Student in an Organized Health Care Education/Training Program — Payments: $480,745
Brandon Howard, Phd, PHD
Student in an Organized Health Care Education/Training Program — Payments: $307,589
Jeffrey Clarke, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $144,902
William Bullock, M.d., Ph.d, M.D., PH.D
Student in an Organized Health Care Education/Training Program — Payments: $132,715
Dr. Neel Thomas, M.d,, M.p.h, M.D,, M.P.H
Student in an Organized Health Care Education/Training Program — Payments: $122,974